What this means
This trial was planned to test a capsule called BGE-117 in people 65 and older with anemia after hip surgery. It was withdrawn, and no results have been posted, so we cannot tell if it works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Withdrawn
- Who can join
- Ages 65 and over · Planned for people 65 and older with anemia after hip surgery; no participants reported
- Where
- 1 site
The science
- Registered title
- Study to Evaluate Efficacy and Safety of BGE-117 in Moderately to Severely Anemic Older Individuals After Major Hip Surgery
- Trial ID
- NCT05152641 ↗
- Phase
- PHASE 2
- Study type
- interventional
- Conditions
- Acute Posthemorrhagic Anemia
- What is tested
- BGE-117, 4mg, Ferrous Sulfate, Matching Placebo, BGE-117, 12mg
- Sponsor
- BioAge Labs, Inc.
- Ages
- 65 Years to no maximum
- Dates
- First posted Dec 10, 2021 · updated May 5, 2022
Registry summary
The purpose of this study is to explore the safety and tolerability of BGE-117 and gain information on the effectiveness of different doses when given to patients 65 years or older with moderate to severe anemia following major hip surgery. BGE-117 is given once daily in a capsule by mouth for up to 12 weeks. Patients are also given oral iron supplements. Anemia following surgery has been associated with decreases in patient functioning. This study will measure improvement of anemia, as well as various patient functioning.
Sites (1)
- Renal Research, Gosford, New South Wales, Australia